Maurizio Marvisi Sara Ramponi Laura Balzarini Chiara Mancini
10.2174/1574886314666190312115648
Curr Drug Saf
2019;14(3):242-245.
hrct icis nsclc pd-1 inhibitors pembrolizimab pneumonitis pulmonary toxicity
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30864509/
Antibodies, Monoclonal, Humanized / adverse effects Lung Diseases / diagnostic imaging
Antibodies, Monoclonal, Humanized / adverse effects Lung Diseases / diagnostic imaging Case Reports Aged Carcinoma, Non-Small-Cell Lung / drug therapy Female Humans Lung Diseases / chemically induced Lung Neoplasms / drug therapy Programmed Cell Death 1 Receptor / immunology Tomography, X-Ray Computed Antibodies, Monoclonal, Humanized PDCD1 protein, human Programmed Cell Death 1 Receptor pembrolizumab
PMC6876257
30864509
A "Crazy Paving" Pattern on CT Scan in a Patient Treated with Pembrolizumab
2019